TC BioPharm (Holdings) PLC (TCBP)
1.39
+0.08
(+6.11%)
USD |
NASDAQ |
Nov 04, 16:00
1.41
+0.02
(+1.44%)
After-Hours: 20:00
TC BioPharm Price to Book Value: 0.5075 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 0.4749 |
| October 31, 2024 | 0.4785 |
| October 30, 2024 | 0.4821 |
| October 29, 2024 | 0.5873 |
| October 28, 2024 | 0.6163 |
| October 25, 2024 | 0.58 |
| October 24, 2024 | 0.7178 |
| October 23, 2024 | 0.7975 |
| October 22, 2024 | 0.9425 |
| October 21, 2024 | 0.8229 |
| October 18, 2024 | 1.834 |
| October 17, 2024 | 1.856 |
| October 16, 2024 | 1.842 |
| October 15, 2024 | 1.845 |
| October 14, 2024 | 1.827 |
| October 11, 2024 | 1.856 |
| October 10, 2024 | 1.860 |
| October 09, 2024 | 1.805 |
| October 08, 2024 | 1.849 |
| October 07, 2024 | 2.113 |
| October 04, 2024 | 2.751 |
| October 03, 2024 | 2.396 |
| October 02, 2024 | 2.146 |
| October 01, 2024 | 1.849 |
| September 30, 2024 | 1.907 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.950 |
| September 26, 2024 | 2.128 |
| September 25, 2024 | 2.266 |
| September 24, 2024 | 2.291 |
| September 23, 2024 | 2.258 |
| September 20, 2024 | 2.244 |
| September 19, 2024 | 2.258 |
| September 18, 2024 | 2.411 |
| September 17, 2024 | 2.483 |
| September 16, 2024 | 2.566 |
| September 13, 2024 | 2.378 |
| September 12, 2024 | 2.229 |
| September 11, 2024 | 1.928 |
| September 10, 2024 | 2.132 |
| September 09, 2024 | 2.048 |
| September 06, 2024 | 2.846 |
| September 05, 2024 | 2.719 |
| September 04, 2024 | 2.599 |
| September 03, 2024 | 2.639 |
| August 30, 2024 | 2.019 |
| August 29, 2024 | 1.936 |
| August 28, 2024 | 1.486 |
| August 27, 2024 | 1.269 |
| August 26, 2024 | 1.486 |
| August 23, 2024 | 1.544 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3597
Minimum
Feb 05 2024
32.34
Maximum
Feb 17 2023
5.657
Average
3.068
Median
Apr 15 2024
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 2.190 |
| Biodexa Pharmaceuticals PLC | 0.2989 |
| Verona Pharma PLC | 18.43 |
| NuCana PLC | 0.7432 |
| Autolus Therapeutics PLC | 1.686 |
Price to Book Value Related Metrics
| Price | 1.39 |
| Earnings Yield | -196.8K% |
| Market Cap | 0.6923M |